Rheological properties of commercially available hyaluronic acid products in the United States for the treatment of osteoarthritis knee pain
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2021;9(22):27 Clinical Medical Insights Arthritis and Musculoskeletal Disorders. 2018;35:523-30Study Summary
The rheological properties of Euflexxa, Orthovisc, Supartz, Monovisc, Synvisc, Synvisc-One, Gel-One and Hyalgan intra-articular hyaluronic acid (IA-HA) products used to treat knee osteoarthritis (OA) were obtained. The values for molecular weight, cross-linking, shear rate and crossover frequency parameters were then compared to the values for healthy knee synovial fluid reported within the current literature.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
